Revelation Biosciences Inc (REVB)
2.37
+0.02
(+0.85%)
USD |
NASDAQ |
May 03, 16:00
2.30
-0.07
(-2.95%)
After-Hours: 20:00
Revelation Biosciences 1 Year Total Returns (Daily): -92.40% for May 3, 2024
1 Year Total Returns (Daily) Chart
Historical 1 Year Total Returns (Daily) Data
Date | Value |
---|---|
May 03, 2024 | -92.40% |
May 02, 2024 | -92.11% |
May 01, 2024 | -93.04% |
April 30, 2024 | -93.50% |
April 29, 2024 | -93.46% |
April 26, 2024 | -93.27% |
April 25, 2024 | -94.10% |
April 24, 2024 | -93.78% |
April 23, 2024 | -94.05% |
April 22, 2024 | -94.11% |
April 19, 2024 | -93.09% |
April 18, 2024 | -93.21% |
April 17, 2024 | -93.87% |
April 16, 2024 | -94.65% |
April 15, 2024 | -94.89% |
April 12, 2024 | -93.00% |
April 11, 2024 | -92.56% |
April 10, 2024 | -93.30% |
April 09, 2024 | -92.89% |
April 08, 2024 | -92.40% |
April 05, 2024 | -92.39% |
April 04, 2024 | -93.03% |
April 03, 2024 | -93.43% |
April 02, 2024 | -93.36% |
April 01, 2024 | -93.18% |
Date | Value |
---|---|
March 28, 2024 | -93.18% |
March 27, 2024 | -94.41% |
March 26, 2024 | -94.34% |
March 25, 2024 | -94.79% |
March 22, 2024 | -94.23% |
March 21, 2024 | -94.04% |
March 20, 2024 | -93.86% |
March 19, 2024 | -94.61% |
March 18, 2024 | -94.35% |
March 15, 2024 | -95.07% |
March 14, 2024 | -95.88% |
March 13, 2024 | -95.00% |
March 12, 2024 | -93.99% |
March 11, 2024 | -93.53% |
March 08, 2024 | -94.78% |
March 07, 2024 | -94.60% |
March 06, 2024 | -95.31% |
March 05, 2024 | -95.10% |
March 04, 2024 | -94.76% |
March 01, 2024 | -94.48% |
February 29, 2024 | -94.54% |
February 28, 2024 | -93.84% |
February 27, 2024 | -94.92% |
February 26, 2024 | -95.10% |
February 23, 2024 | -95.78% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
-98.99%
Minimum
Feb 06 2024
4.00%
Maximum
Nov 17 2021
-87.26%
Average
-94.52%
Median
1 Year Total Returns (Daily) Benchmarks
Cardiff Oncology Inc | 89.25% |
Ocular Therapeutix Inc | -0.32% |
Ocugen Inc | 90.49% |
Cue Biopharma Inc | -52.98% |
Solid Biosciences Inc | 90.57% |